ANTI-INFLAMMATORY DRUGS MARKET ANALYSIS

Anti-inflammatory Drugs Market, By Drug Type (Nonsteroidal Anti-inflammatory Drugs (NSAlDs), Immune Selective Anti-inflammatory Derivatives (ImSAlDs), Anti-inflammatory Biologics, Corticosteroids), By Application (Arthritis, Chronic Obstructive Pulmonary Disease (COPD), Multiple Sclerosis, Inflammatory Bowel Disease (IBD), Gout, Others), By Route of Administration (Oral, Topical, Injection, Inhalation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Jul 2024
Code : CMI4327
Pages :200
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Anti-inflammatory drugs market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Increasing R&D investments

Increasing research and development investments by pharmaceutical companies can drive the global anti-inflammatory drugs market growth. These companies are investing heavily in R&D activities to develop novel and more effective treatment options for inflammation-related chronic diseases. According to the data from Organisation for Economic Co-operation and Development (OECD), the average R&D spending as a percentage of sales by pharmaceutical firms had increased from 12.3% in 2010 to 13.4% in 2020. The existing anti-inflammatory drugs are associated with several side effects on long-term use such as gastrointestinal issues. Therefore, there is high need for advanced anti-inflammatory treatment with improved safety profiles. The R&D efforts are primarily focused on developing biologics and new targeted therapies to treat chronic inflammation. For example, companies are researching on cytokine and chemokine pathway inhibitors that can block specific molecules responsible for inflammation. Some firms are also exploring stem cell and gene therapies for rheumatoid arthritis and inflammatory bowel disease.

Key Players Insights